Galmed Pharmaceuticals (GLMD) Return on Sales (2016 - 2019)

Galmed Pharmaceuticals' Return on Sales history runs 4 years deep, the most recent figure standing at 0.05% for Q2 2019.

• In Q2 2019, Return on Sales fell 5.0% year-over-year to 0.05%; the TTM figure through Jun 2019 stood at 0.05% (down 6.0% YoY), while the FY2018 annual figure was 0.05%, down 7.0% from the prior year.
• Return on Sales was 0.05% for Q2 2019 at Galmed Pharmaceuticals, up from 0.05% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.19% in Q3 2016 to a low of 0.01% in Q3 2018.
• Historically, Return on Sales has averaged 0.1% across 4 years, with a median of 0.1% in 2017.
• Biggest YoY gain for Return on Sales was 0 bps in 2018; the steepest drop was 10 bps in 2018.
• A 4-year view of Return on Sales shows it stood at 0.18% in 2016, then declined by 24 bps to 0.13% in 2017, then sank by 64 bps to 0.05% in 2018, then rose by 7 bps to 0.05% in 2019.
• The last three Return on Sales figures came in at 0.05% (Q2 2019), 0.05% (Q4 2018), and 0.01% (Q3 2018), per Business Quant data.